Type 2 Diabetes Mellitus Clinical Trial
Official title:
Raspberries, Postprandial Metabolism and Type 2 Diabetes Mellitus
Verified date | January 2018 |
Source | Oklahoma State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Raspberries are high in several phytochemicals, vitamin C and B vitamins and have been shown
to be potent antioxidants and anti-inflammatory agents. However, human interventional studies
reporting the effects of raspberries in obesity, T2DM and associated oxidative stress and
inflammation are limited. Aims, objectives and methods:
Aim 1: To assess the effects of raspberries in postprandial glycemia and lipemia following a
high-fat fast-food style meal challenge versus control group Objectives: to execute this aim,
the investigators will conduct analyses of serum glucose, insulin and lipids (total
cholesterol, LDL-cholesterol, triglycerides, VLDL-cholesterol and HDL-cholesterol) at fasting
(baseline) and at postprandial 1,2,4 hours of high-fat, fast food style breakfast
consumption. The investigators will also calculate homoeostasis model assessment of insulin
resistance (HOMA-IR) at these time points using serum glucose and insulin values.
Aim 2: To assess the effects of raspberries in postprandial vascular functions (blood
pressure and artery elasticity) and inflammation following a high-fat fast food style meal
challenge versus control group
Objectives: to execute this aim, the investigators will measure C-reactive protein (CRP) and
the following parameters of vascular function associated with CVD at fasting (baseline) and
at postprandial 1,2,4 hours of high-fat, fast food style breakfast consumption:
- systolic blood pressure and diastolic blood pressure
- large artery elasticity index and small artery elasticity index
- systemic vascular resistance
Status | Completed |
Enrollment | 25 |
Est. completion date | December 2017 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 21 Years to 60 Years |
Eligibility |
Inclusion Criteria: - type 2 diabetes Exclusion Criteria: - not having type 2 diabetes |
Country | Name | City | State |
---|---|---|---|
United States | Oklahoma State University | Stillwater | Oklahoma |
Lead Sponsor | Collaborator |
---|---|
Oklahoma State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Postprandial blood glucose | Postprandial blood glucose will be measured at fasting, 1, 2 and 4 hours following meals with or without raspberries | postprandial 4 hours | |
Primary | Postprandial blood lipids | Postprandial blood lipids will be measured at fasting, 1, 2 and 4 hours following meals with or without raspberries | postprandial 4 hours | |
Secondary | Postprandial inflammation | Postprandial C-reactive protein and interleukins will be measured at fasting, 1, 2 and 4 hours following meals with or without raspberries | postprandial 4 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02252224 -
Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance
|